Insider Trading activities of Zymogenetics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zymogenetics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zymogenetics Inc since year 2005. Table 2 shows the detailed insider transactions of Zymogenetics Inc since 2005. The reporting company's ticker symbol is ZGEN. The reporting company's CIK number is 1129425.
The total value of stock buying since 2005 is $27,132,567.
The total value of stock sales since 2005 is $223,509,822.
The total value of stock option exercises since 2005 is $3,061,506.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Zymogenetics Inc (ZGEN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2010-10 0 $0 22,143,320 $215,897,370 0 $0
2010-09 0 $0 20,000 $195,000 20,000 $55,540
2010-08 0 $0 0 $0 498,000 $1,383,444
2010-07 0 $0 20,000 $79,200 20,000 $55,540
2010-02 0 $0 1,324 $7,492 0 $0
2010-01 1,250,000 $7,500,000 0 $0 0 $0
2009-12 0 $0 10,000 $70,000 10,000 $27,780
2009-08 0 $0 10,000 $60,000 10,000 $27,780
2008-03 589,024 $5,502,560 0 $0 0 $0
2008-02 704,242 $6,756,634 0 $0 0 $0
2007-09 597,510 $6,961,288 0 $0 0 $0
2007-08 32,750 $412,085 0 $0 0 $0
2007-03 0 $0 9,000 $137,700 9,000 $24,993
2006-10 0 $0 2,232 $40,176 2,232 $10,539
2006-09 0 $0 2,232 $40,698 2,232 $10,539
2006-08 0 $0 36,464 $721,632 33,464 $101,611
2006-05 0 $0 2,232 $47,412 2,232 $10,539
2006-04 0 $0 96,232 $2,010,808 96,232 $629,095
2006-03 0 $0 86,232 $1,897,494 83,232 $336,616
2006-02 0 $0 25,000 $538,250 35,000 $165,200
2006-01 0 $0 86,000 $1,712,590 80,000 $222,290
2005-05 0 $0 3,000 $54,000 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Zymogenetics Inc insiders (ZGEN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-10-08 Novo Nordisk A S (Other) Sale 22,143,320 9.75 215,897,370
2010-09-08 Johnson James A (Executive VP and CFO) Sale 20,000 9.75 195,000
2010-09-08 Johnson James A (Executive VP and CFO) Option Ex 20,000 2.78 55,540
2010-08-19 Carter Bruce L A (Director) Option Ex 426,000 2.78 1,183,428
2010-08-17 Penhoet Edward (Director) Option Ex 72,000 2.78 200,016
2010-07-30 Hamby Darren R (Sr. VP, HR & Corp Svcs) Sale 20,000 3.96 79,200
2010-07-30 Hamby Darren R (Sr. VP, HR & Corp Svcs) Option Ex 20,000 2.78 55,540
2010-02-24 Miller Dennis M. (Sr VP, Resrch & Preclin Devl) Sale 662 5.66 3,746
2010-02-24 Ramos Eleanor (Sr. VP, Chief Medical Officer) Sale 662 5.66 3,746
2010-01-07 Novo Nordisk A S (10% Owner) Buy 1,250,000 6.00 7,500,000
2009-12-07 Johnson James A (Executive VP and CFO) Sale 10,000 7.00 70,000
2009-12-07 Johnson James A (Executive VP and CFO) Option Ex 10,000 2.78 27,780
2009-08-31 Johnson James A (Executive VP and CFO) Sale 10,000 6.00 60,000
2009-08-31 Johnson James A (Executive VP and CFO) Option Ex 10,000 2.78 27,780
2008-03-07 Landy Joseph (10% Owner) Buy 56,722 8.66 490,928
2008-03-07 Leff Jonathan S (Director) Buy 56,722 8.66 490,928
2008-03-05 Landy Joseph (10% Owner) Buy 98,254 9.32 915,923
2008-03-05 Leff Jonathan S (Director) Buy 98,254 9.32 915,923
2008-03-03 Landy Joseph (10% Owner) Buy 139,536 9.64 1,344,429
2008-03-03 Leff Jonathan S (Director) Buy 139,536 9.64 1,344,429
2008-02-29 Landy Joseph (10% Owner) Buy 93,009 10.03 932,787
2008-02-29 Leff Jonathan S (Director) Buy 93,009 10.03 932,787
2008-02-28 Landy Joseph (10% Owner) Buy 10,142 9.95 100,953
2008-02-28 Leff Jonathan S (Director) Buy 10,142 9.95 100,953
2008-02-26 Landy Joseph (10% Owner) Buy 1,900 9.48 18,012
2008-02-26 Leff Jonathan S (Director) Buy 1,900 9.48 18,012
2008-02-25 Landy Joseph (10% Owner) Buy 145,000 9.60 1,391,275
2008-02-25 Leff Jonathan S (Director) Buy 145,000 9.60 1,391,275
2008-02-21 Landy Joseph (10% Owner) Buy 96,570 9.16 885,064
2008-02-21 Leff Jonathan S (Director) Buy 96,570 9.16 885,064
2008-02-19 Carter Bruce L A (CEO & Chairman of the Board) Buy 11,000 9.13 100,452
2007-09-13 Landy Joseph (10% Owner) Buy 73,972 11.72 867,099
2007-09-13 Leff Jonathan S (Director) Buy 73,972 11.72 867,099
2007-09-12 Landy Joseph (10% Owner) Buy 60,483 11.43 691,502
2007-09-12 Leff Jonathan S (Director) Buy 60,483 11.43 691,502
2007-09-11 Landy Joseph (10% Owner) Buy 163,300 11.70 1,909,793
2007-09-11 Leff Jonathan S (Director) Buy 163,300 11.70 1,909,793
2007-09-04 Williams Douglas E (President and CSO) Buy 2,000 12.25 24,500
2007-08-14 Nielsen Kurt Anker (Director) Buy 3,000 12.65 37,950
2007-08-13 Harper James A (Director) Buy 4,000 12.80 51,200
2007-08-03 Maccallum David (Director) Buy 10,000 12.51 125,100
2007-08-03 Carter Bruce L A (CEO & Chairman of the Board) Buy 15,750 12.56 197,835
2007-03-28 Ohrstrom Jan K (Sr. VP, Business Development) Sale 9,000 15.30 137,700
2007-03-28 Ohrstrom Jan K (Sr. VP, Business Development) Option Ex 9,000 2.78 24,993
2006-10-10 Shema Suzanne M (Senior VP, General Counsel) Sale 2,232 18.00 40,176
2006-10-10 Shema Suzanne M (Senior VP, General Counsel) Option Ex 2,232 4.72 10,539
2006-09-12 Shema Suzanne M (Senior VP, General Counsel) Sale 2,232 18.23 40,698
2006-09-12 Shema Suzanne M (Senior VP, General Counsel) Option Ex 2,232 4.72 10,539
2006-08-24 Ohrstrom Jan K (Sr. VP, Business Development) Sale 4,000 20.04 80,160
2006-08-24 Ohrstrom Jan K (Sr. VP, Business Development) Option Ex 4,000 2.78 11,108
2006-08-24 Carter Bruce L A (President & CEO) Sale 25,000 20.04 501,000
2006-08-24 Carter Bruce L A (President & CEO) Option Ex 25,000 2.78 69,425
2006-08-24 Johnson James A (Senior Vice President and CFO) Sale 3,000 20.04 60,120
2006-08-09 Shema Suzanne M (Senior VP, General Counsel) Sale 85 18.00 1,530
2006-08-09 Shema Suzanne M (Senior VP, General Counsel) Option Ex 85 4.72 401
2006-08-08 Shema Suzanne M (Senior VP, General Counsel) Sale 4,379 18.00 78,822
2006-08-08 Shema Suzanne M (Senior VP, General Counsel) Option Ex 4,379 4.72 20,677
2006-05-09 Shema Suzanne M (Senior VP, General Counsel) Sale 2,232 21.24 47,412
2006-05-09 Shema Suzanne M (Senior VP, General Counsel) Option Ex 2,232 4.72 10,539
2006-04-17 Henell Fredrik (Sr VP Business Development) Sale 16,000 20.98 335,728
2006-04-17 Henell Fredrik (Sr VP Business Development) Option Ex 16,000 15.64 250,240
2006-04-17 Young Mark D (Sr VP, Technical Operations) Sale 26,000 20.98 545,558
2006-04-17 Young Mark D (Sr VP, Technical Operations) Option Ex 26,000 4.72 122,772
2006-04-11 Shema Suzanne M (Senior VP, General Counsel) Sale 2,232 20.27 45,244
2006-04-11 Shema Suzanne M (Senior VP, General Counsel) Option Ex 2,232 4.72 10,539
2006-04-10 Young Mark D (Sr VP, Technical Operations) Sale 26,000 20.09 522,418
2006-04-10 Young Mark D (Sr VP, Technical Operations) Option Ex 26,000 4.72 122,772
2006-04-04 Young Mark D (Sr VP, Technical Operations) Sale 26,000 21.61 561,860
2006-04-04 Young Mark D (Sr VP, Technical Operations) Option Ex 26,000 4.72 122,772
2006-03-27 Young Mark D (Sr VP, Technical Operations) Sale 52,000 22.16 1,152,424
2006-03-27 Young Mark D (Sr VP, Technical Operations) Option Ex 52,000 4.72 245,544
2006-03-14 Shema Suzanne M (SVP Intellectual Prop. & Legal) Sale 2,232 21.98 49,070
2006-03-14 Shema Suzanne M (SVP Intellectual Prop. & Legal) Option Ex 2,232 4.72 10,539
2006-03-13 Ohrstrom Jan K (Sr. VP, Commercial Operations) Sale 4,000 21.75 87,000
2006-03-13 Ohrstrom Jan K (Sr. VP, Commercial Operations) Option Ex 4,000 2.78 11,108
2006-03-13 Carter Bruce L A (President & CEO) Sale 25,000 21.75 543,750
2006-03-13 Carter Bruce L A (President & CEO) Option Ex 25,000 2.78 69,425
2006-03-13 Johnson James A (Senior VP and CFO) Sale 3,000 21.75 65,250
2006-02-27 Young Mark D (Sr VP, Technical Operations) Option Ex 10,000 4.72 47,200
2006-02-23 Young Mark D (Sr VP, Technical Operations) Sale 25,000 21.53 538,250
2006-02-23 Young Mark D (Sr VP, Technical Operations) Option Ex 25,000 4.72 118,000
2006-01-12 Ohrstrom Jan K (Sr. VP, Commercial O) Sale 12,000 22.66 271,920
2006-01-12 Ohrstrom Jan K (Sr. VP, Commercial O) Option Ex 12,000 2.78 33,336
2006-01-12 Johnson James A (Senior VP and CFO) Sale 10,000 22.66 226,600
2006-01-12 Johnson James A (Senior VP and CFO) Option Ex 10,000 2.78 27,780
2006-01-09 Ohrstrom Jan K (Sr. VP, Commercial O) Sale 4,000 20.01 80,040
2006-01-09 Ohrstrom Jan K (Sr. VP, Commercial O) Option Ex 4,000 2.78 11,112
2006-01-09 Carter Bruce L A (President & CEO) Sale 25,000 19.92 498,000
2006-01-09 Carter Bruce L A (President & CEO) Option Ex 25,000 2.78 69,500
2006-01-09 Johnson James A (Senior VP and CFO) Sale 3,000 20.01 60,030
2006-01-05 Ohrstrom Jan K (Sr. VP, Commercial O) Sale 4,000 18.00 72,000
2006-01-05 Ohrstrom Jan K (Sr. VP, Commercial O) Option Ex 4,000 2.78 11,112
2006-01-05 Carter Bruce L A (President & CEO) Sale 25,000 18.00 450,000
2006-01-05 Carter Bruce L A (President & CEO) Option Ex 25,000 2.78 69,450
2006-01-05 Johnson James A (Senior VP and CFO) Sale 3,000 18.00 54,000
2005-05-17 Johnson James A (Senior VP and CFO) Sale 3,000 18.00 54,000

Insider trading activities including stock purchases, stock sales, and option exercises of ZGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zymogenetics Inc (symbol ZGEN, CIK number 1129425) see the Securities and Exchange Commission (SEC) website.